World's Best Scientists 2026 revealed!
Christer Halldin

Christer Halldin

Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
112
Citations
47626
World Ranking
5135
National Ranking
103

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award
  • 2012 - Member of Academia Europaea

Overview

Christer Halldin is affiliated with the Karolinska Institute in Sweden and has a substantial body of research primarily in the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Neuroscience. Their work includes significant contributions to subfields such as Radiology, Nuclear Medicine and Imaging, Molecular Biology, Cellular and Molecular Neuroscience, Neurology, and Psychiatry and Mental Health.

Halldin's research focuses on topics including Medical Imaging Techniques and Applications, Neuroscience and Neuropharmacology Research, Radiopharmaceutical Chemistry and Applications, Neurological Disorders and Treatments, Receptor Mechanisms and Signaling, Parkinson's Disease Mechanisms and Treatments, as well as Advanced MRI Techniques and Applications.

The scientist's frequent publication venues highlight their research presence in:

  • ACS Chemical Neuroscience
  • EJNMMI Research
  • Nuclear Medicine and Biology
  • Journal of Cerebral Blood Flow & Metabolism
  • Journal of Medicinal Chemistry

Notable recent papers by Christer Halldin include:

  • The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases (2023, Nature Communications)
  • A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression (2020, Translational Psychiatry)
  • Guidelines for the content and format of PET brain data in publications and archives: A consensus paper (2020, Journal of Cerebral Blood Flow & Metabolism)
  • Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study (2020, Neuro-Oncology)
  • Positron emission tomographic imaging in drug discovery (2021, Drug Discovery Today)

Frequent collaborators in Halldin's research include Sangram Nag, Andrea Varrone, Lars Farde, Ryosuke Arakawa, and Magnus Schou.

In 2012, Christer Halldin was recognized as a Member of the Academia Europaea.

Best Publications

  • The gut microbiota influences blood-brain barrier permeability in mice

    Viorica Braniste;Maha Al-Asmakh;Czeslawa Kowal;Farhana Anuar

  • Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects

    Lars Farde;Anna-Lena Nordström;Frits-Axel Wiesel;Stefan Pauli

  • Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs

    Lars Farde;Fritz-Axel Wiesel;Christer Halldin;Göran Sedvall

  • Age-related cognitive deficits mediated by changes in the striatal dopamine system.

    Lars Bäckman;Nathalie Ginovart;Roger A. Dixon;Tarja-Brita Robins Wahlin

  • D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

    Lars Farde;Frits-Axel Wiesel;Sharon Stone-Elander;Christer Halldin

  • Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

    Anna-Lena Nordström;Lars Farde;Frits-Axel Wiesel;Kaj Forslund

  • Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.

    L. Farde;L. Eriksson;G. Blomquist;C. Halldin

  • Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.

    Håkan Hall;Göran Sedvall;Olle Magnusson;Jutta Kopp

  • Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

    J. S. Fowler;R. R. MacGregor;A. P. Wolf;C. D. Arnett

  • D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.

    A L Nordström;L Farde;S Nyberg;P Karlsson

  • Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

    Katarina Varnäs;Christer Halldin;Håkan Hall

  • No D2 receptor increase in PET study of schizophrenia.

    Lars Farde;Frits-Axel Wiesel;HÅkan Hall;Christer Halldin

  • PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

    L Farde;C Halldin;S Stone-Elander;G Sedvall

  • The role of the striatal dopamine transporter in cognitive aging

    Nina Erixon-Lindroth;Lars Farde;Tarja-Brita Robins Wahlin;Judit Sovago

  • Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635

    H Hall;C Lundkvist;C Halldin;L Farde

  • Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.

    Svante Nyberg;Bo Eriksson;Gabriella Oxenstierna;Christer Halldin

  • PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.

    N Ginovart;A Lundin;L Farde;C Halldin

  • Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

    Aurelija Jucaite;Elisabeth Fernell;Christer Halldin;Hans Forssberg

  • Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors

    Christer Halldin;Lars Farde;Thomas Högberg;Nina Mohell

  • Synthesis of L- and D-[methyl-11C]methionine.

    Bengt Långström;Gunnar Antoni;Per Gullberg;Christer Halldin

Frequent Co-Authors

Lars Farde
Lars Farde Karolinska Institute
Balázs Gulyás
Balázs Gulyás Nanyang Technological University
Andrea Varrone
Andrea Varrone Karolinska Institute
Göran Sedvall
Göran Sedvall Karolinska Institute
Victor W. Pike
Victor W. Pike National Institutes of Health
Håkan Hall
Håkan Hall Karolinska Institute
Robert B. Innis
Robert B. Innis National Institutes of Health
Bengt Långström
Bengt Långström Uppsala University
Håkan Wikström
Håkan Wikström University of Groningen
Kjell Någren
Kjell Någren Odense University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare pathways can complement or provide a stepping stone into a medical career in the USA. For nurses aiming to advance quickly, dnp online programs offer a flexible route to a Doctor of Nursing Practice degree, accessible from anywhere with a reliable internet connection.

Those seeking even faster advancement may be interested in a 1 year dnp program online, which is designed for experienced nurses ready to accelerate their leadership or clinical expertise.

Not everyone starts their journey as a registered nurse. If you want to enter nursing sooner, an accelerated lpn program can quickly prepare you for practical nursing roles, making it easier to launch your healthcare career.

Specializing in mental health is another promising path. The fastest psych np program enables qualified nurses to focus on psychiatric-mental health, fueling both career growth and the urgent need for mental health professionals.

These online degrees and accelerated pathways make healthcare education more accessible and tailored to diverse career goals in the medical field.

Best Scientists Citing Christer Halldin

Trending Scientists

Recently Published Articles